Back to News
quantum-computing

Lemonade Stock Turned 21% Sweeter Last Month. Here's How.

The Motley Fool
Loading...
4 min read
0 likes
⚡ Quantum Brief
AI-driven insurer Lemonade surged 21.1% in March 2026, rebounding from February’s steep selloff, though it remains 12% down year-to-date. The volatile rally included a mid-month spike and late-month pullback amid macroeconomic pressures. Morgan Stanley’s March 17 upgrade to Buy with an $85 price target—citing Lemonade’s new autonomous vehicle insurance for Tesla and an unnamed EV partnership—triggered a 15.8% single-day jump on heavy volume. CEO Daniel Schreiber’s March 4 blog post, “Why Incumbents Won’t Catch Up,” framed Lemonade’s AI-native model as superior to legacy insurers like GEICO, highlighting inefficiencies in outdated systems and boosting investor confidence pre-upgrade. Lemonade joined the NASDAQ Internet Index on March 25, potentially increasing passive fund inflows, though broader market volatility—fueled by oil prices, inflation, and geopolitical risks—limited further gains. Despite unprofitability and high valuation, Lemonade’s 50%+ revenue growth, improving loss ratios, and AI-driven disruption narrative attract long-term investors betting on its tech-driven insurance transformation.
Lemonade Stock Turned 21% Sweeter Last Month. Here's How.

Summarize this article with:

By Anders Bylund – Apr 2, 2026 at 12:34PM ESTKey PointsLemonade shares rose 21% in March, bouncing back from a steep February selloff.Morgan Stanley upgraded the stock to Buy on March 17, sparking a 15.8% single-day jump.The stock remains down 12% year to date despite March's strong performance.Shares of Lemonade (LMND 0.92%) rose 21.1% in March 2026, according to data from S&P Global Market Intelligence. The AI-powered insurance company bounced back from a brutal February sell-off, though the ride was anything but smooth. The path from $52 to $63 included a mid-month spike, a late-month stumble, and plenty of volatility in between. The stock is still down 12% for the year, but at least the bleeding has paused. ExpandNYSE: LMNDLemonadeToday's Change(-0.92%) $-0.56Current Price$60.51Key Data PointsMarket Cap$4.7BDay's Range$57.78 - $61.8852wk Range$24.31 - $99.90Volume22KAvg Vol2.6M Why Lemonade spiked mid-month (and stumbled at the end) The biggest single-day move came on March 17, when Lemonade shares jumped 15.8% on heavy volume. Analyst firm Morgan Stanley upgraded the stock to Buy and raised its price target from $80 to $85, citing Lemonade's new autonomous vehicle insurance product for self-driving Tesla (TSLA 5.40%) cars, and a partnership with an unnamed EV manufacturer. When a major bank says nice things about your AI strategy, people listen. CEO Daniel Schreiber didn't let analysts do all the talking, though. His March 4 blog post, "Why Incumbents Won't Catch Up," read like a manifesto for AI-native disruption. The piece compared Lemonade's efficiency metrics to legacy giants like Berkshire Hathaway's (BRKA +0.03%) (BRKB 0.19%) GEICO (which apparently runs on 600 systems that don't talk to each other). Schreiber's post wasn't subtle. Effective? Maybe. The stock was up 9% by the time Morgan Stanley weighed in two weeks later, reversing February's deep dive. The company also joined the NASDAQ Internet Index on March 25. That's not necessarily headline news, but index inclusion can boost trading volumes via passive fund flows. Then the macro gremlins showed up. Rising oil prices, inflation concerns, and geopolitical uncertainty sent investors fleeing from growth stocks. Lemonade's March jump could have been substantially higher. Image source: Getty Images. Is Lemonade's rally sustainable? Lemonade's stock chart in 2026 looks like a heart-rate monitor during a horror movie. Up 15% on February's earnings, down 20% the next week due to valuation concerns in an unpredictable economy, up 21% in March, and still underwater for the year. Lemonade is not a stock for the faint of heart. But zoom out and the picture looks different. Revenue is growing at a rate north of 50%. Loss ratios are improving. Cash flow has turned positive in recent reports. The company keeps signing deals and expanding its insurance products, while its services are turning more effective and profitable thanks to heaps of real-world risk data. Lemonade's stock is expensive, for sure. The company is still unprofitable and shares are trading at the highest price-to-sales ratio in the property and casualty insurance sector. And insurance regulators move at roughly the speed of continental drift, on a cold day. But Schreiber's core argument is hard to dismiss: Lemonade was built for AI from the ground up, while incumbents are trying to teach an old-school industry how to code. That doesn't mean the stock goes up tomorrow or next month. But for investors who believe AI will reshape insurance, Lemonade's 12% year-to-date decline may look more like a buying opportunity than a warning sign. Personally, I doubled down on my Lemonade holdings two weeks ago, a few days after the Morgan Stanley bump. I expect great things from this disruptive innovator.Read NextApr 2, 2026 •By Anthony Di Pizio2 Under-the-Radar Growth Stocks That Just Got Cheaper Thanks to the Market Sell-OffMar 22, 2026 •By Jack DelaneyIs Lemonade a Buy After Morgan Stanley's Upgrade?Mar 20, 2026 •By Eric VolkmanWhy Lemonade Stock Soared by 16% This WeekMar 20, 2026 •By Matt DiLalloBest Up-and-Coming Companies to Invest in for 2026Mar 18, 2026 •By Micah ZimmermanGot $3,000? 3 Growth Stocks Trading Below What Wall Street Thinks They're Worth.Mar 17, 2026 •By James BrumleyWhy Lemonade Stock Is Up More Than 15% on TuesdayAbout the AuthorAnders Bylund is a contributing Motley Fool media and technology analyst covering semiconductors, cloud computing, internet infrastructure, quantum computing, and streaming media. Previously, Anders was a systems administrator for Nielsen Technology and CSX, gaining hands-on experience with enterprise-class systems. He was also a freelance writer for Ars Technica, TIME, USA Today, CNN, WIRED, and AOL's Daily Finance. He holds a bachelor’s degree in English and a master’s degree in library and information sciences from Florida State University. He believes in coyotes and time as an abstract.TMFZahrimX@TMFZahrimStocks MentionedLemonadeNYSE: LMND$60.48(-0.97%)-$0.59Berkshire HathawayNYSE: BRKA$716,434.49(+0.03%)+$176.49Berkshire HathawayNYSE: BRKB$477.28(-0.26%)-$1.22TeslaNASDAQ: TSLA$360.48(-5.45%)-$20.78Morgan StanleyNYSE: MS$165.55(-0.37%)-$0.62*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Read Original

Tags

partnership

Source Information

Source: The Motley Fool